Skip to main content

Table 1 Clinical and biochemical characteristics of NAFLD Compared with Control Subjects.

From: Elevated endotoxin levels in non-alcoholic fatty liver disease

  NAFLD Controls P-value
Age
(yrs)
49.1 ± 12.6 44.6 ± 9.9 NS
BMI
(kg/m 2 )
34.0 ± 6.0 26.4 ± 4.5 0.0001
Endotoxin #:
(EU/mL)
10.6(7.8, 14.8) 3.9(3.2, 5.2) 0.0001
Fatty Liver # 11.7(7.3, 15.6) n/a 0.0001
NASH # 10.5(8.0, 14.0) n/a 0.0001
Cirrhosis # 7.1(5.2, 11.2) n/a 0.01
Insulin #
(μU/mL)
18.5(10.3, 28.8) 12.9(10.6, 16.0) 0.001
Glucose #
(mmol/L)
5.5(4.8, 6.5) 5.3(4.9, 6.2) NS
HOMA-IR # 4.2(2.5, 7.5) 3.1(2.4, 4.1) 0.001
TNF-α #
(pg/mL)
5.8(4.5, 8.1) 11.2(9.5, 12.2) 0.0001
sCD14 #
(ng/mL)
1623(1370, 2013) 1431.3 ± (1244, 1827) NS
sTNFRII #
(pg/mL)
2229.2(1865.6, 2879.9) 2253.2(1900.4, 2536.5) NS
  1. Data are presented as mean (± SD) unless log transformed (#) in which case they are presented as mean (interquartile range).